PATENT CLAIM ANALYSIS

Application Number: 15866924
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["514", "544000"]

Abstract:
The present application relates to compounds and methods for reducing the severity of convulsant activity or epileptic seizures, or for the treatment of chronic or acute pain.

Claim (Index 3):
The method of  claim 2 , wherein R 3 =H;\n C(O)R 5 , wherein R 5 =H, CH 3 , C 2 H 5 , CH(CH 3 ) 2 , CHCH 3 CN, or aryl; C(O)\u2014O\u2014R 6 , wherein R 6 =pharmaceutically acceptable salts, H, C1 to C6 alkyl (straight chain or branched), CH 2 C 6 H 5 , or CH(CH 2 )n, and wherein n=2-5; C(O)NH 2 , C(O)NHR 6  or C(O)NR 7 R 8  wherein R 7  and R 8  independently=C1 to C6 alkyl (straight chain or branched), CH 2 C 6 H 5 , aryl, or R 7  and R 8  together=(CH 2 )n, and wherein n=3-5; or OH, OCH 3 , or OCH 2 C 6 H 5 .

Metadata:
- Claim Count in Document: 20.0
- Percentile: 86.0
- Lexical Diversity: 1.20833
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15858183', '15309357', '13216927', '15412667', '12981233']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7662829272563579
- 35 USC 102 Novelty (BERT): 0.5318105942819583
- Combined Prediction Score: 0.742835693958918
- Mean Citation Score: 318.422452
- Max Citation Score: 323.6101700000001
- Similarity Product: 211.81686230780969

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test